Inflammatory Bowel Disease
Crohn's Disease (CD) and Ulcerative Colitis (UC), collectively known as inflammatory bowel disease (IBD), are two of the…
Chicago, United StatesEst. completion Sep 1, 2026
Crohn Disease (CD)
This multicenter, randomized, controlled trial aims to evaluate the efficacy and safety of standard-dose tumor necrosis …
Guangzhou, ChinaEst. completion Dec 31, 2028
Ulcerative Colitis (UC)Inflammatory Bowel Disease (IBD)Colitis
This Phase 2b randomized, double-blind, placebo-controlled, multicenter trial will evaluate the efficacy and safety of a…
Izmir, Turkey (Türkiye)Est. completion May 30, 2027
Ulcerative ColitisInflammatory Bowel DiseasesColitisColitis, Ulcerative
This is a Phase 2, multicenter, proof-of-concept platform study in adult participants with moderately to severely active…
Canoga Park, United StatesEst. completion Jun 2026
Crohn's Disease
The purpose of this protocol is to evaluate the efficacy and safety of tulisokibart in participants with moderately to s…
Dothan, United StatesEst. completion Oct 30, 2028
Colitis, Ulcerative
The purpose of this study is to assess how well JNJ-78934804 works (efficacy) and how safe it is (safety) as compared to…
Anaheim, United StatesEst. completion Aug 11, 2028
Crohn Disease
The purpose of this study is to assess how well JNJ-78934804 works (efficacy) and how safe it is (safety) as compared to…
Anaheim, United StatesEst. completion Jun 12, 2028
Ulcerative Colitis
The purpose of this study is to determine the safety, efficacy, and pharmacokinetics (PK) of etrasimod for the treatment…
Little Rock, United StatesEst. completion Jun 16, 2029
Ulcerative Colitis (UC)Ulcerative Colitis (Disorder)Ulcerative Colitis AcuteIBD (Inflammatory Bowel Disease)CD - Crohn's Disease
A Phase 1, 2-part, randomised, double-blind, placebo-controlled, FIH study to determine the safety, tolerability, and PK…
Hangzhou, ChinaEst. completion Dec 31, 2026
Inflammatory Bowel DiseaseColitis, UlcerativeCrohn's Disease
The purpose of this study is to evaluate the clinical effectiveness (how well the treatment works) of Guselkumab, by lin…
Harrow, United KingdomEst. completion Mar 5, 2029
Crohn Disease
The purpose of this study is to assess how well guselkumab works when compared to risankizumab in participants with mode…
Dothan, United StatesEst. completion Nov 15, 2028
Colitis, Ulcerative
The purpose of this protocol is to evaluate the efficacy (how well it works), safety and tolerability of oral icotrokinr…
Chandler, United StatesEst. completion Jan 14, 2028
Crohn's Disease
Crohn's disease (CD) is a long-lasting disease that causes severe inflammation (redness, swelling), in the digestive tra…
Dothan, United StatesEst. completion Jan 2030
Crohn Disease
The purpose of this study is to evaluate how well guselkumab works in participants with Crohn's disease (CD; a long-term…
Guangzhou, ChinaEst. completion Sep 15, 2027
Crohn Disease
The purpose of this study is to evaluate how-well icotrokinra works (clinical efficacy) and how safe it is (safety) in p…
Chandler, United StatesEst. completion Sep 19, 2028
Inflammatory Bowel DiseaseUlcerative ColitisChrohn's Disease
This study will investigate in patients with Crohn s disease and ulcerative colitis how the body s immune system control…
Bethesda, United States
Colitis, Ulcerative
The purpose of this study is to assess the measurable changes in health, function, or quality of life (clinical outcomes…
Beijing, ChinaEst. completion Jun 30, 2028
Crohn Disease (CD)Ileocolic ResectionPost-endoscopic Operative Reccurence
Crohn's disease (CD) (\> 200,000 patients in France) is a chronic inflammatory disease that can lead to progression of i…
Amiens, FranceEst. completion Mar 1, 2027
Crohn's Disease
The purpose of this study is to evaluate the clinical and endoscopic efficacy of guselkumab in pediatric participants wi…
Los Angeles, United StatesEst. completion Oct 27, 2027
Ulcerative Colitis
The goal of this clinical trial is to determine the clinical effects of two different dietary fibre supplements, acacia …
Edmonton, CanadaEst. completion Dec 2027